629|49|Public
25|$|PEDF, {{a protein}} with many functions, has been {{suggested}} to play a clinical role in choroidal neovascularization, cardiovascular disease, diabetes, diabetic macular edema, osteogenesis imperfecta and cancer. As an antiangiogenic protein, PEDF may help suppress unwanted neovascularization of the eye. Molecules that shift the balance towards PEDF and away from VEGF may prove useful tools in both choroidal neovascularization and preventing cancer <b>metastasis</b> <b>formation.</b>|$|E
2500|$|NFAT {{transcription}} {{factors are}} implicated in breast cancer, more {{specifically in the}} process of cell motility at the basis of <b>metastasis</b> <b>formation.</b> Indeed, NFAT1 (NFATC2) and NFAT5 are pro-invasive and pro-migratory in breast carcinoma [...] and NFAT3 (NFATc4) is an inhibitor of cell motility.|$|E
2500|$|Similar {{mutations}} {{are also}} frequently {{seen in the}} β-catenin recruiting motifs of APC. Hereditary loss-of-function mutations of APC cause a condition known as Familial Adenomatous Polyposis. Affected individuals develop hundreds of polyps in their large intestine. Most of these polyps are benign in nature, but they {{have the potential to}} transform into deadly cancer as time progresses. Somatic mutations of APC in colorectal cancer are also not uncommon. [...] Beta-catenin and APC are among the key genes (together with others, like K-Ras and SMAD4) involved in colorectal cancer development. The potential of β-catenin to change the previously epithelial phenotype of affected cells into an invasive, mesenchyme-like type contributes greatly to <b>metastasis</b> <b>formation.</b>|$|E
40|$|Wnt/b-catenin {{signalling}} pathway plays {{important roles}} in embryonic development and carcinogenesis. Overactivation of the pathway {{is one of the}} most common driving forces in major cancers such as colorectal and breast cancers. The downstream effectors of the pathway and its regulation of carcinogenesis and metastasis are still not very well understood. In this study, which was based on two genome-wide transcriptomics screens, we identify MENA (ENAH, Mammalian enabled homologue) as a novel transcriptional target of the Wnt/b-catenin signalling pathway. We show that the expression of MENA is upregulated upon overexpression of degradation-resistant b-catenin. Promoters of all mammalian MENA homologues contain putative binding sites for Tcf 4 transcription factor – the primary effector of the Wnt/b-catenin pathway and we demonstrate functionality of these Tcf 4 -binding sites using luciferase reporter assays and overexpression of b-catenin, Tcf 4 and dominant-negative Tcf 4. In addition, lithium chloride-mediated inhibition of GSK 3 b also resulted in increase in MENA mRNA levels. Chromatin immunoprecipitation showed direct interaction between b-catenin and MENA promoter in Huh 7 and HEK 293 cells and also in mouse brain and liver tissues. Moreover, overexpression of Wnt 1 and Wnt 3 a ligands increased MENA mRNA levels. Additionally, knock-down of MENA ortholog in D. melanogaster eyeful and sensitized eye cancer fly models resulted in increased tumor and <b>metastasis</b> <b>formations.</b> In summary, our study identifies MENA a...|$|R
40|$|Wnt/β-catenin {{signalling}} pathway plays {{important roles}} in embryonic development and carcinogenesis. Overactivation of the pathway {{is one of the}} most common driving forces in major cancers such as colorectal and breast cancers. The downstream effectors of the pathway and its regulation of carcinogenesis and metastasis are still not very well understood. In this study, which was based on two genome-wide transcriptomics screens, we identify MENA (ENAH, Mammalian enabled homologue) as a novel transcriptional target of the Wnt/β-catenin signalling pathway. We show that the expression of MENA is upregulated upon overexpression of degradation-resistant β-catenin. Promoters of all mammalian MENA homologues contain putative binding sites for Tcf 4 transcription factor - the primary effector of the Wnt/β-catenin pathway and we demonstrate functionality of these Tcf 4 -binding sites using luciferase reporter assays and overexpression of β-catenin, Tcf 4 and dominant-negative Tcf 4. In addition, lithium chloride-mediated inhibition of GSK 3 β also resulted in increase in MENA mRNA levels. Chromatin immunoprecipitation showed direct interaction between β-catenin and MENA promoter in Huh 7 and HEK 293 cells and also in mouse brain and liver tissues. Moreover, overexpression of Wnt 1 and Wnt 3 a ligands increased MENA mRNA levels. Additionally, knock-down of MENA ortholog in D. melanogaster eyeful and sensitized eye cancer fly models resulted in increased tumor and <b>metastasis</b> <b>formations.</b> In summary, our study identifies MENA as novel nexus for the Wnt/β-catenin and the Notch signalling cascades. status: publishe...|$|R
30|$|It {{has been}} {{reported}} that approximately 0.4 % of RCC metastasizes to skeletal muscle (Ali et al. 2011; Gözen et al. 2009; Sakamoto et al. 2007). Despite its rich blood supply and large surface area, skeletal muscle metastasis is very rare (Pompo et al. 2008; Pompo et al. 2009). Presence of protease inhibitors in the basement membrane inhibiting cell invasion, increased lactic acid levels and acidic environment interfering with tumor cell growth, presence of peptidic factors preventing the metastasis, muscular contractions dislodging the anchored tumor cells all provide insight into the rarity of skeletal metastasis. (Pompo et al. 2008; Taira et al. 2005; Ali et al. 2011; Gözen et al. 2009). Additionally, the scarcity or absence of specific receptors which influence the metastatic potential in RCC, the oncogene transgene bypassing the primary site and pre-selection of the organs of <b>metastasis</b> with <b>formation</b> of favorable environment by bone marrow cells may provide further explanation (Pompo et al. 2008).|$|R
50|$|NFAT {{transcription}} {{factors are}} implicated in breast cancer, more {{specifically in the}} process of cell motility at the basis of <b>metastasis</b> <b>formation.</b> Indeed, NFAT1 (NFATC2) is pro-invasive and pro-migratory in breast carcinoma.|$|E
50|$|NFAT {{transcription}} {{factors are}} implicated in breast cancer, more {{specifically in the}} process of cell motility at the basis of <b>metastasis</b> <b>formation.</b> Indeed, NFAT3 (NFATc4) is an inhibitor of cell motility by blocking the expression of LCN2.|$|E
50|$|Arginine and proline {{metabolism}} {{is one of}} {{the central}} pathways for the biosynthesis of the amino acids arginine and proline from glutamate. The pathways linking arginine, glutamate, and proline are bidirectional. Thus, the net utilization or production of these amino acids is highly dependent on cell type and developmental stage.Altered proline metabolism has been linked to <b>metastasis</b> <b>formation</b> in breast cancer.|$|E
40|$|Platelets {{are highly}} {{reactive}} {{components of the}} circulatory system, which exert not only haemostatic activity but {{also contribute to the}} modulation of various pathological conditions including inflammation, atherosclerosis and cancer metastasis through the release of cytokines, chemokines and the presentation of several adhesion molecules. During cancer <b>metastasis,</b> the <b>formation</b> of platelet–tumor cell aggregates in the circulation facilitates immune evasion and the microvascular arrest of tumor cells at distant sites. Several adhesion molecules, such as integrins and glycoproteins, were shown to be involved in this process. Recent findings indicate that P-selectin is another main mediator of platelet–tumor cell interactions. Other effects of activated platelets on cancer progression are associated with a release of platelet-derived factors stimulating tumor growth and angiogenesis. Any interference in platelet–tumor cell interactions resulted in attenuation of cancer metastasis. The well recognized, albeit not fully characterized function of platelets during cancer progression defines platelets as potential targets for cancer therapy. Specifically, the rapid expression of P-selectin on the cell surface of activated platelets and its strong association with metastasis provide a rationale for P-selectin inhibition as an antimetastatic treatment...|$|R
40|$|Peritoneal carcinosis is a local/regional {{dissemination}} of digestive malignancies, gynaecological malignancies {{or other forms}} of cancer with or without proof of the existence of systemic <b>metastasis.</b> Mode of <b>formation</b> and evolution is controlled by several factors, mainly physical (the primary tumor, presence or absence of ascites, peristaltics, peritoneal fluid absorption, gravity, intraabdominal liquid) and of minor importance the biological factors (aggressiveness of cancer). We analyzed 17 cases of carcinosis from pancreas neoplasia, operated and neoperate in history. It sought to determine the distribution of peritoneal metastatic implants and quantification of peritoneal cancer index (PCI), based on imaging examinations and by surgical exploration (laparoscopic or laparotomy). We evaluated the distribution and redistribution in such conditions depending on tumor location, gender of patients, surgical intervention and concomitant pathological conditions...|$|R
5000|$|Due to the {{invasive}} {{nature of}} invadopodia in cancer cells, {{research has been}} done focusing on targeting invadopodia as a potential therapeutic target to inhibit <b>metastasis.</b> Inhibiting invadopodia <b>formation</b> by targeting Src kinase with Saracatanib in a chicken model system showed a decreased incidence of invadopodia and decreased cancer extravasation. In mice, inhibiting invadopodia formation directly, through RNAi against tks4 or tks5, significantly reduced cancer extravasation. [...] Screening for drug activators and inhibitors of invadopodia revealed that Cdc5 can be a target for inhibiting invadopodia formation and also that paclitaxel, a drug commonly used to treat cancer, induces invadopodia formation. While these results show promise for invadopodia as a therapeutic target, more research needs to be done before any drugs can be approved for this use.|$|R
50|$|AGR2 protein {{has been}} {{demonstrated}} to interact with C4.4A and DAG-1 proteins which are associated with <b>metastasis</b> <b>formation</b> since these transmembrane proteins are involved in cell and matrix interactions between cancer and normal cells. AGR2 is able to suppress p53 activity by preventing phosphorylation after DNA damage. AGR2 {{has been shown to}} bind to Reptin, a tumor repressor, in the nucleus.|$|E
50|$|PEDF, {{a protein}} with many functions, has been {{suggested}} to play a clinical role in choroidal neovascularization, cardiovascular disease, diabetes, diabetic macular edema, osteogenesis imperfecta and cancer. As an antiangiogenic protein, PEDF may help suppress unwanted neovascularization of the eye. Molecules that shift the balance towards PEDF and away from VEGF may prove useful tools in both choroidal neovascularization and preventing cancer <b>metastasis</b> <b>formation.</b>|$|E
5000|$|NFAT {{transcription}} {{factors are}} implicated in breast cancer, more {{specifically in the}} process of cell motility at the basis of <b>metastasis</b> <b>formation.</b> Indeed, NFAT1 (NFATC2) and NFAT5 are pro-invasive and pro-migratory in breast carcinoma [...] and NFAT3 (NFATc4) is an inhibitor of cell motility.NFAT1 regulates the expression of the TWEAKR and its ligand TWEAK with the Lipocalin 2 to increase breast cancer cell invasion and NFAT3 inhibits Lipocalin 2 expression to blunt the cell invasion.|$|E
40|$|One of {{the major}} {{prognostic}} factors in rectal cancer is lymph node <b>metastasis.</b> The <b>formation</b> of lymph node metastases {{is dependent on the}} existence of a premetastatic niche. An important factor preceding metastasis are lymph vessels which are located in the lymph node. Accordingly, the occurrence of intranodal lymphangiogenesis is thought to indicate distant metastasis and worse prognosis. To evaluate the significance of lymph node lymphangiogenesis, we studied formalin fixed, paraffin embedded adenocarcinomas and regional lymph nodes of 203 rectal cancer patients who were treated with neoadjuvant radiochemotherapy and consecutive curative surgery with cancer free surgical margins (R 0). Regional lymph node lymph vessels were detected by immunohistochemistry for podoplanin (D 2 - 40). Our results show that the presence of lymphatic vessels in regional lymph nodes significantly affects the disease-free survival in univariate and multivariate analyses. In contrast, there was no correlation between peritumoral or intratumoral lymph vessel density and prognosis. Indeed, our study demonstrates the importance of lymphangiogenesis in regional lymph nodes after neoadjuvant radiochemotherapy and consecutive surgery as an independent prognostic marker. Staining for intranodal lymphangiogenesis and methods of intravital imaging of lymphangiogenesis and lymphatic flow may be a useful strategy to predict longterm outcome in rectal cancer patients. Furthermore, addition of VEGF-blocking agents to standardized neoadjuvan...|$|R
40|$|Alicja Krejner, 1 Malgorzata Litwiniuk, 1 – 3 Tomasz Grzela 11 Laboratory of Cell Molecular Biology, Department of Histology and Embryology, Biostructure Research Center, Medical University of Warsaw, Warsaw, Poland; 2 Postgraduate School of Molecular Medicine, Medical University of Warsaw, Warsaw, Poland; 3 Department of Otolaryngology, Medical University of Warsaw, Warsaw, PolandAbstract: Matrix metalloproteinases (MMPs) are key {{effector}} molecules {{responsible for}} extracellular matrix (ECM) turnover. They {{are involved in}} tissue remodeling and regeneration. Although the main targets for MMPs are ECM components, they are also able to digest a variety of non-ECM molecules including cytokines, their receptors, or carriers. Therefore, {{the activity of the}} MMPs remains under tight control. However, when controlling mechanisms are ineffective, MMPs may become highly dangerous molecules, which have a strong destructive effect on affected tissues. Apart from cancer <b>metastasis,</b> aneurysm <b>formation,</b> or airway remodeling in asthma, MMPs have also been identified as main detrimental factors in delayed healing of chronic wounds. In this short review, we describe main representatives of MMPs family, their role in pathophysiology of chronic wounds, as well as current and possible therapeutic strategies for modulation of MMPs’ activity, which may be useful in management of chronic wounds. Keywords: chronic wound, MMPs, MMP inhibitors, wound treatmen...|$|R
40|$|AbstractSince their {{discovery}} in 1986, Ral (Ras-like) GTPases {{have emerged as}} critical regulators of diverse cellular functions. Ral-selective guanine nucleotide exchange factors (RalGEFs) function as downstream effectors of the Ras oncoprotein, and the RalGEF–Ral signaling network comprises the third best characterized effector of Ras-dependent human oncogenesis. Because of this, Ral GTPases {{as well as their}} effectors are being explored as possible therapeutic targets in the treatment of RAS mutant cancer. The two Ral isoforms, RalA and RalB, interact with a variety of downstream effectors and have been found to play key and distinct roles in both normal and neoplastic cell physiology including regulation of vesicular trafficking, migration and invasion, tumor <b>formation,</b> <b>metastasis,</b> and gene expression. In this review we provide an overview of Ral biochemistry and biology, and we highlight recent discoveries...|$|R
50|$|Though {{expressed}} highly in {{eye lens}} and muscle tissues, αBC {{can also be}} found in several types of cancer, among which head and neck squamous cell carcinoma (HNSCC) and breast carcinomas. αBC expression is associated with <b>metastasis</b> <b>formation</b> in HNSCC and in breast carcinomas and in other types of cancer, expression is often correlated with poor prognosis as well. The expression of αBC can be increased during various stresses, like heat shock, osmotic stress or exposure to heavy metals, which then may lead to prolonged survival of cells under these conditions.|$|E
50|$|Tumour {{associated}} macrophages (TAM) {{are typical}} for their protumoural functions like promotion of cancer cell motility, <b>metastasis</b> <b>formation</b> and angiogenesis and their formation {{is dependent on}} microenvironmetal factors which are present in developing tumour.TAMs produce immunosuppressive cytokines like IL-10, TGFβ and PGE2 very small amount of NO or ROI {{and low levels of}} inflammatory cytokines (IL-12, IL-1β, TNFα, IL-6). Ability of TAMs to present tumour-associated antigens is decreased as well as stimulation of the anti-tumour functions of T and NK cells. Also TAMs are not able to lyse tumour cells. Targeting of TAM may be a novel therapeutic strategy against cancer.|$|E
5000|$|Similar {{mutations}} {{are also}} frequently {{seen in the}} β-catenin recruiting motifs of APC. Hereditary loss-of-function mutations of APC cause a condition known as Familial Adenomatous Polyposis. Affected individuals develop hundreds of polyps in their large intestine. Most of these polyps are benign in nature, but they {{have the potential to}} transform into deadly cancer as time progresses. Somatic mutations of APC in colorectal cancer are also not uncommon. [...] Beta-catenin and APC are among the key genes (together with others, like K-Ras and SMAD4) involved in colorectal cancer development. The potential of β-catenin to change the previously epithelial phenotype of affected cells into an invasive, mesenchyme-like type contributes greatly to <b>metastasis</b> <b>formation.</b>|$|E
40|$|Laparoscopic surgery {{has been}} {{incorporated}} into common surgical practice. The peritoneum is an organ with various biologic functions that may be affected in different ways by laparoscopic and open techniques. Clinically, these alterations may be important in issues such as peritoneal <b>metastasis</b> and adhesion <b>formation.</b> A literature search using the Pubmed and Cochrane databases identified articles focusing on the key issues of laparoscopy, peritoneum, inflammation, morphology, immunology, and fibrinolysis. Laparoscopic surgery induces alterations in the peritoneal integrity and causes local acidosis, probably due to peritoneal hypoxia. The local immune system and inflammation are modulated by a pneumoperitoneum. Additionally, the peritoneal plasmin system is inhibited, leading to peritoneal hypofibrinolysis. Similar to open surgery, laparoscopic surgery affects both the integrity and biology of the peritoneum. These observations may have implications for various clinical condition...|$|R
40|$|Ó The Author(s) 2010. This {{article is}} {{published}} with open access at Springerlink. com Background Laparoscopic surgery has {{been incorporated into}} common surgical practice. The peritoneum is an organ with various biologic functions that may be affected in different ways by laparoscopic and open techniques. Clinically, these alterations may be important in issues such as peritoneal <b>metastasis</b> and adhesion <b>formation.</b> Methods A literature search using the Pubmed and Cochrane databases identified articles focusing on the key issues of laparoscopy, peritoneum, inflammation, morphology, immunology, and fibrinolysis. Results Laparoscopic surgery induces alterations in the peritoneal integrity and causes local acidosis, probably due to peritoneal hypoxia. The local immune system and inflammation are modulated by a pneumoperitoneum. Additionally, the peritoneal plasmin system is inhibited, leading to peritoneal hypofibrinolysis. Conclusion Similar to open surgery, laparoscopic surgery affects both the integrity and biology of the peritoneum. These observations may have implications for various clinical conditions...|$|R
40|$|AbstractRecently, much {{attention}} has been given to chitosan and its hydrolyzed products due to their diverse biological activities. For the first time here we report the inhibitory effect of chitooligosaccharides (COS) on activation and expression of matrix metalloproteinase- 2 (MMP- 2) in primary human dermal fibroblasts (HDFs). COS with 3 – 5 kDa exhibited the highest inhibitory effect on MMP- 2 activity in HDFs assessed by gelatin zymography. Interestingly, protein expression of MMP- 2 was also inhibited by COS with same molecular weight. This inhibition was caused by the decrease of the gene expression and transcriptional activity of MMP- 2. Furthermore, it was found that COS repressed the gene expression of c-fos, a part of AP- 1 transcription factor. These results suggest that COS may {{play an important role in}} the prevention and treatment of MMP- 2 mediated several health problems such as <b>metastasis</b> and wrinkle <b>formation...</b>|$|R
5000|$|In {{molecular}} biology, HOTTIP (HOXA transcript at {{the distal}} tip) {{is a long}} non-coding RNA. The gene encoding HOTTIP {{is located at the}} 5' tip of the HOXA locus, and coordinates the activation of several of the 5' HOXA genes. The non-coding RNA is brought into close proximity with the HOXA genes by chromosomal looping. HOTTIP binds to the WDR5 protein, which forms a complex with the histone methyltransferase protein MLL. This targets the WDR5-MLL complex to the HOXA region and results in H3K4 methylation and transcriptional activation of the HOXA locus.More recently, HOTTIP has been shown {{to play a role in}} Hepatocellular Carcinoma (HCC) progression. HOTTIP expression levels predict <b>metastasis</b> <b>formation</b> and poor disease outcome in HCC patients. HOTTIP has been shown to be transcriptionally regulated by a transcriptional coactivator PSIP1/p52 ...|$|E
50|$|Georg F. Weber {{has defined}} the genetic basis of <b>metastasis</b> <b>formation</b> as {{aberrant}} expression or splicing {{of a unique}} set of developmentally non-essential genes (stress response genes) that physiologically mediate the homing of immune system cells.Specifically, his laboratory has studied the cytokine osteopontin, which acts as a metastasis gene in multiple malignancies, including breast cancer. Based on the molecular mechanisms of osteopontin induction and function in cancer metastasis, he has established the following paradigms:1. Osteopontin and variant CD44 interact, and this is essential for metastasis by several types of cancer. 2. Multiple osteopontin splice variants are present in malignant, but not in benign human breast tumor cells.3. Metastasis genes support anchorage-independence in an autocrine fashion.4. In cancer cells, distinct signal transduction pathways to growth and invasiveness are activated by oncogenes. 5. The expression (activation) of metastasis genes is triggered by cellular stress response programs and is regulated by multi-subunit transcription factor complexes.|$|E
40|$|The {{development}} of secondary distant organ and lymph node metastasis has an extraordinary {{impact on the}} {{prognosis of patients with}} solid cancer. In most cases the advent of metastatic growth represents the turning point from a local, potentially curable, disease to a systemic non-curable situation. As a highly regulated process, <b>metastasis</b> <b>formation</b> follows a distinct, non-random pattern characteristic for each tumor entity. <b>Metastasis</b> <b>formation</b> and strategies to prevent this lethal event in the progression of cancer is of fundamental interest for cancer science and patient care. In this special issue of Cancers, papers highlighting cellular mechanisms of <b>metastasis</b> <b>formation,</b> genetic and epigenetic aspects associated with organ and tumor specific <b>metastasis</b> <b>formation,</b> as well as papers outlining experimental and clinical therapeutic concepts for anti-metastatic treatment are included...|$|E
40|$|Tamayo-Orbegozo {{have contributed}} equally to this work. Besides their {{essential}} role in hemostasis and thrombosis, platelets {{are involved in the}} onset of cancer metastasis by interacting with tumor cells. Platelets release secretory fac-tors that promote tumor growth, angiogenesis, and <b>metastasis.</b> Furthermore, the <b>formation</b> of platelet–tumor cell aggregates in the bloodstream provides cancer cells with an immune escape mechanism by protecting circulating malignant cells from immune-mediated lysis by natural killer (NK) cells. Platelet–tumor cell interaction is accomplished by specific adhe-sion molecules, including integrins, selectins, and their ligands. Podocalyxin-like protein 1 (PCLP 1) is a selectin-ligand protein in which overexpression has been associated with several aggressive cancers. PCLP 1 expression enhances cell adherence to platelets in an integrin-dependent process and through the interaction with P-selectin expressed on activated platelets. However, the involvement of PCLP 1 -induced tumor–platelet interaction in tumor immune evasion still remains unexplored. The identification of selectin ligand...|$|R
50|$|During {{the primary}} {{infection}}, F. necrophorum colonizes the infection {{site and the}} infection spreads to the parapharyngeal space. The bacteria then invade the peritonsillar blood vessels where they can spread to the internal jugular vein. In this vein, the bacteria cause {{the formation of a}} thrombus containing these bacteria. Furthermore, the internal jugular vein becomes inflamed. This septic thrombophlebitis can give rise to septic microemboli that disseminate {{to other parts of the}} body where they can form abscesses and septic infarctions. The first capillaries that the emboli encounter where they can nestle themselves are the pulmonary capillaries. As a consequence, the most frequently involved site of septic metastases are the lungs, followed by the joints (knee, hip, sternoclavicular joint, shoulder and elbow). In the lungs, the bacteria cause abscesses, nodulary and cavitary lesions. Pleural effusion is often present. Other sites involved in septic <b>metastasis</b> and abscess <b>formation</b> are the muscles and soft tissues, liver, spleen, kidneys and nervous system (intracranial abscesses, meningitis).|$|R
40|$|As a redhead I {{have had}} a {{personal}} interest in red hair, freckles and sunburns since childhood. An observation of a formaldehyde-induced fluorescence in human epidermal melanocytes initiated my scientific interest in these cells. Prota and Nicolaus demonstrated that oxidation products of cysteinyldopas are {{the main components of}} pheomelanin. Our identification of 5 -S-cysteinyldopa as the source of formaldehyde-induced fluorescence of normal and pathological melanocytes started a series of investigations into this amino acid, enzymatic and non-enzymatic oxidation of catecholic compounds and the metabolism of thiols. All melanocytes with functioning tyrosinase produce cysteinyldopas and the levels of 5 -S-cysteinyldopa in serum and urine are related to the size and pigment forming activity of the melanocyte population. The determination of 5 -S-cysteinyldopa in serum or urine is a sensitive diagnostic method in the detection of melanoma <b>metastasis.</b> Some non-specific <b>formation</b> of cysteinyldopa is present in the body, as demonstrated by 5 -S-cysteinyldopa in individuals with tyrosinase-negative albinism...|$|R
40|$|Metastases {{are thought}} to arise from cancer stem cells and their tumor {{initiating}} abilities are required {{for the establishment of}} metastases. Nevertheless, in metastatic melanoma, the nature of cancer stem cells is under debate and their contribution to <b>metastasis</b> <b>formation</b> remains unknown. Using an experimental metastasis model, we discovered that high levels of the WNT receptor, FZD 7, correlated with enhanced metastatic potentials of melanoma cell lines. Knocking down of FZD 7 in a panel of four melanoma cell lines led to a significant reduction in lung metastases in animal models, arguing that FZD 7 plays a causal role during <b>metastasis</b> <b>formation.</b> Notably, limiting dilution analyses revealed that FZD 7 is essential for the tumor initiation of melanoma cells and FZD 7 knockdown impeded the early expansion of metastatic melanoma cells shortly after seeding, in accordance with the view that tumor initiating ability of cancer cells is required for <b>metastasis</b> <b>formation.</b> FZD 7 activated JNK in melanoma cell lines in vitro and the expression of a dominant negative JNK suppressed <b>metastasis</b> <b>formation</b> in vivo, suggesting that FZD 7 may promote metastatic growth of melanoma cells via activation of JNK. Taken together, our findings uncovered a signaling pathway that regulates the tumor initiation of melanoma cells and contributes to <b>metastasis</b> <b>formation</b> in melanoma...|$|E
40|$|The {{present study}} {{of the effect of}} heparin and dextran 1000 on the <b>metastasis</b> <b>formation</b> after i. v. tumour cell {{injection}} in dextran non-sensitive rats using a syngeneic 20 -methylcholanthrene induced fibrosarcoma showed that heparin treatment decreased with formation of pulmonary metastases in animals both untreated and treated with dextran 1000. Treatment with dextran 1000 increased the formation of pulmonary metastases in animals both untreated and treated with heparin and the effect of dextran 1000 was thus not affected by heparin treatment. Heparin did not have any direct action on the tumour cells, which influenced <b>metastasis</b> <b>formation.</b> The data suggest that heparin acts as an anticoagulant with decreased microthrombus formation around lodged cells and that dextrax 1000 stimulates <b>metastasis</b> <b>formation</b> primarily by mechanisms other than intravascular coagulation...|$|E
40|$|Sex-associated {{differences}} in bone <b>metastasis</b> <b>formation</b> from breast, lung, and prostate cancer exist in clinical studies, {{but have not}} been systematically reviewed. Differences in the bone marrow niche {{can be attributed to}} sexual dimorphism, to genetic variations that affect sex hormone levels, or to the direct effects of sex hormones, natural or exogenously delivered. This review describes the present understanding of sex-associated and sex hormone level {{differences in}} the marrow niche and in formation of bone metastasis during the transition of these three cancers from treatable disease to an often untreatable, lethal metastatic one. Our purpose is to provide insight into some underlying molecular mechanisms for hormonal influence in bone <b>metastasis</b> <b>formation,</b> and to the potential influence of sexual dimorphism, genetic differences affecting sex assignment, and sex hormone level differences on the bone niche and its favorability for <b>metastasis</b> <b>formation.</b> We reviewed publications in PubMed and EMBASE, including full length manuscripts, case reports, and clinical studies of relevance to our topic. We focused on bone <b>metastasis</b> <b>formation</b> in breast, lung, and prostate cancer because all three commonly present with bone metastases. Several clear observations emerged. For breast cancer bone <b>metastasis</b> <b>formation,</b> estrogen receptor (ER) signaling pathways indicate a role for ER beta (ERβ). Estrogen influences the bone microenvironment, creating and conditioning a favorable niche for colonization and breast cancer progression. For lung cancer, studies support the hypothesis that females have a more favorable bone microenvironment for <b>metastasis</b> <b>formation.</b> For prostate cancer, a decrease in the relative androgen to estrogen balance or a “feminization” of bone marrow favors bone <b>metastasis</b> <b>formation,</b> with a potentially important role for ERβ that may be similar to that in breast cancer. Long-term estrogen administration or androgen blockade in males may feminize the bone marrow niche to one more favorable for bone metastases in prostate cancer. Administration of androgens in females, especially combined with mastectomy, may reduce risk of developing bone metastatic breast cancer. We conclude that it should be considered that females, those with female-leaning genetic variations, or hormonal states that feminize the bone marrow, may offer favorable sites for bone metastases...|$|E
40|$|Until recently, {{inflammatory}} chemokines {{were viewed}} mainly as indispensable “gate keepers” of immunity and inflammation. However, updated {{research indicates that}} cancer cells subvert the normal chemokine system and these molecules and their receptors become important constituents of the tumor microenvironment with very different ways to exert tumor-promoting roles. The CCR 5 and the CCL 5 ligand have been detected in some hematological malignancies, lymphomas, and {{a great number of}} solid tumors, but extensive studies {{on the role of the}} CCL 5 /CCR axis were performed only in a limited number of cancers. This review summarizes updated information on the role of CCL 5 and its receptor CCR 5 in cancer cell proliferation, <b>metastasis,</b> and the <b>formation</b> of an immunosuppressive microenvironment and highlights the development of newer therapeutic strategies aimed to inhibit the binding of CCL 5 to CCR 5, to inhibit CCL 5 secretion, or to inhibit the interactions among tumor cells and the microenvironment leading to CCL 5 secretion...|$|R
40|$|Tumor {{morphological}} evolution: directed {{migration and}} gain {{and loss of}} the self-metastatic phenotype Heiko Enderling, Lynn Hlatky and Philip Hahnfeldt* Background: Aside from the stepwise genetic alterations known to underlie cancer cell creation, the microenvironment is known to profoundly influence subsequent tumor development, morphology and <b>metastasis.</b> Invasive cluster <b>formation</b> has been assumed {{to be dependent on}} directed migration and a heterogeneous environment- a conclusion derived from complex models of tumor-environment interaction. At the same time, these models have not included the prospect, now supported by a preponderance of evidence, that only a minority of cancer cells may have stem cell capacity. This proves to weigh heavily on the microenvironmental requirements for the display of characteristic tumor growth phenotypes. We show using agent-based modeling that some defining features of tumor growth ascribed to directed migration might also be realized under random migration, and discuss broader implications for cause-and-effect determination in general. Results: Considering only the properties of random migration in tumors composed of stem cells and committed cells...|$|R
40|$|Attribution License, which permits {{unrestricted}} use, distribution, {{and reproduction}} in any medium, provided the original work is properly cited. Until recently, inflammatory chemokines were viewed mainly as indispensable “gate keepers ” of immunity and inflammation. However, updated {{research indicates that}} cancer cells subvert the normal chemokine system and thesemolecules and their receptors become important constituents of the tumormicroenvironmentwith very different ways to exert tumor-promoting roles. TheCCR 5 and the CCL 5 ligand have been detected in some hematological malignancies, lymphomas, and {{a great number of}} solid tumors, but extensive studies {{on the role of the}} CCL 5 /CCR axis were performed only in a limited number of cancers. This review summarizes updated information on the role of CCL 5 and its receptor CCR 5 in cancer cell proliferation, <b>metastasis,</b> and the <b>formation</b> of an immunosuppressivemicroenvironment and highlights the development of newer therapeutic strategies aimed to inhibit the binding of CCL 5 to CCR 5, to inhibit CCL 5 secretion, or to inhibit the interactions among tumor cells and the microenvironment leading to CCL 5 secretion. 1...|$|R
